baber/WOPTO huggingface dataset:
Patent BR-PI0908702-B1 (BR)
Title: Sistema pessoal de detecção de quedas e método para uso de um sistema pessoal de detecção de quedas
Inventor: NINGJIANG CHEN
IPC: A61B5/00
Filed: 2009-05-05
Abstract: sistema pessoal de detecção de quedas e método para uso de um sistema pessoal de detecção de quedas é apresentado um sistema pessoal de detecção de quedas que compreende um módulo sensor que é apropriado para fixação a um usuário, e o módulo sensor compreende um acelerômetro para medir as acelerações que agem no módulo sensor; e um processador para analisar as acelerações medidas a fim de determinar se o módulo sensor sofreu um impacto e para estimar um deslocamento vertical do módulo sensor durante um período de tempo imediatamente antes do impacto; sendo que o processador estima o deslocamento vertical do módulo sensor ao integrar duas vezes as medições do acelerômetro.
Patent BR-PI0910595-B1 (BR)
Title: processo para a produção de composto de pirimidina
Inventor: AKIHIKO ISOGAI
IPC: C07D401/12
Filed: 2009-04-16
Abstract: "PROCESSO PARA A PRODUÇÃO DE COM-POSTO DE PIRIMIDINA". A presente invenção refere-se a um processo para a produção de um composto de pirimidina útil como um intermediário para substâncias químicas ou farmacêuticas para agricultura, que seja de operação simples, apresenta alto rendimento e produz apenas uma pequena quantidade de subprodutos. O processo compreende reagir um composto representado pela fórmula (I) com um composto representado pela fórmula (II) na presença de um composto de piridina para produzir um composto representado pela fórmula (III), um composto representado pela fórmula (IV) ou mistura dos mesmos.
Patent BR-PI0914836-B1 (BR)
Title: Conduto para transportar um efluente petrolífero
Inventor: ALAIN COUTAREL
IPC: B32B27/18
Filed: 2009-06-16
Abstract: conduto para transportar um efluente petrolífero o conduto é destinado a transportar um efluente petrolífero que compreende pelo menos um dos compostos ácidos co2 e h2s. o conduto compreende pelo menos um elemento metálico (3, 5) e uma bainha tubular feita de material polimérico (2, 4), o elemento metálico sendo disposto no exterior da bainha. a bainha é composta por uma mistura de um material polimérico com uma quantidade determinada de produtos quimicamente ativos com os ditos compostos ácidos de modo a neutralizar irreversivelmente os efeitos corrosivos dos ditos compostos e limitar os efeitos corrosivos sobre os ditos elementos metálicos. o conduto é caracterizado pelo fato de que os produtos quimicamente ativos são introduzidos na bainha sob a forma de partículas de superfície específica superior a 5 m2/g.
Patent BR-PI0919658-B1 (BR)
Title: Material ativo de cátodo, mistura de cátodo, cátodo para baterias secundárias e bateria secundária de lítio
Inventor: CHEOL-HEE PARK
IPC: H01M4/62
Filed: 2009-10-22
Abstract: material ativo de cátodo que fornece eficiência e densidade de energia do eletrodo aperfeiçoadas. trata-se de um material ativo de cátodo que tem uma composição representada pela seguinte fórmula i: life(p1-xo4) (i), em que uma fração molar (l-x) de fósforo (p) se situa na faixa de 0,910 a 0,999, para permitir que a eficiência operacional do material ativo de cátodo seja nivelada a uma eficiência operacional inferior de um material ativo de ânodo e para aperfeiçoar a densidade de energia do material ativo de cátodo. adicionalmente, um material ativo de cátodo, em que uma fração molar (l-x) de fósforo (p) é menor do que 1, contém tanto fe2+ como fe3+, evitando, assim, de maneira vantajosa a deformação estrutural, aperfeiçoando a condutividade iônica, exibindo propriedades de taxa superior e inibindo a queda de ir sob a carga/descarga, conferindo, deste modo, a alta densidade de energia para as baterias.
Patent BR-PI1012668-B1 (BR)
Title: estrutura de fornecimento de energia para um aparelho de alimentação de combustível
Inventor: MICHIRU FUKUDA
IPC: F04D13/08
Filed: 2010-02-01
Abstract: estrutura de fornecimento de energia para um aparelho de alimentação de combustível a estrutura divulgada é provida com um acoplador do lado de suporte (32) com uma partição do lado de acoplador (56) a qual é provida na unidade de alimentação elétrica de uma bomba de combustível (4), e que divide terminais de fornecimento de energia do lado de suporte (33) embutidos dentro; tampas do lado de suporte (51), que estão montadas com uma vedação líquida ao perímetro externo da porção condutora dos terminais de conexão (50), os quais se conectam aos terminais de fornecimento de energia do lado de suporte (33), e que formam uma vedação líquida entre o interior e exterior do acoplador do lado de suporte (32) que está montado no acoplador do lado de suporte (32); e um apoio de terminal do lado de suporte (45) que prende as tampas do lado de suporte (51), fixando-as ao acoplador do lado de suporte (32). a estrutura revelada pode prevenir de modo confiável ocorrência de corrosão de terminais sem usar um material de vedação, e pode prevenir a separação de terminais de conexão.
Patent BR-PI1100336-B1 (BR)
Title: Sistema atuador para uma válvula de segurança kellyguard disposta em uma coluna de perfuração para extração de petróleo ou gás e método para a montagem de um sistema atuador para uma válvula de segurança kellyguard disposta em uma coluna de perfuração
Inventor: LEONARD G CHILDERS
IPC: E21B21/10
Filed: 2011-02-24
Abstract: sistema atuador para uma válvula de segurança kellyguard disposta em uma coluna de perfuração para extração de petróleo ou gás, método para a montagem de um sistema atuador para uma válvula de segurança kellyguard disposta em uma coluna de perfuração e método para a operação de uma válvula de segurança kellyguard presa em uma coluna de perfuração. trata-se de método e sistema atuador para uma válvula de segurança kellyguard disposta em uma coluna de perfuração. o sistema atuador inclui uma luva (52), que inclui uma cavidade; um atuador (54) disposto no interior da cavidade e. corifigurado para girar a válvula de segurança kellyguard; em que as primeira é segunda regiões externas (68a, 68b) da luva (52) têm vários orifícios configurados para receberem um meio sobre pressão para atuar o atuador (54); um anel (56) fornecido em volta da luva (52) e configurado para ficar preso, em que o anel (56) têm primeiro e segundo sulcos internos (70a, 70b); e primeira e segunda vedações (58a, 58b) fornecidas no interior dos primeiro e segundo sulcos (70a, 70b), respectivamente, em que pelo menos uma entre as primeira e segunda vedações (58a, 58b) são configuradas para que não toquem as primeira ou segunda regiões externas (68a, 68b) da luva (52), quando em estado de colapso e para que toquem as primeira ou segunda regiões externas (68a, 68b) quando em um estado inflado.
Patent BR-PI1101685-B1 (BR)
Title: Processo de detecção e monitoramento de microrganismo patogênico de pós-colheita
Inventor: ROSA MARIA VALDEBENITO SANHUEZA
IPC: C12Q1/06
Filed: 2011-04-29
Abstract: processo de detecção e monitoramento de microrganismo patogênico de pós-colheita. a presente invenção se refere a um método rápido, prático e de fácil execução para detectar e/ou monitorar microrganismo patogênico de pós-colheita desenvolvido tendo como modelo o fungo peniclilium expansum. este é um importante agente etiológico para o setor alimentício e saúde animal devido à sua capacidade de produzir um metabólito carcinogânico denominado patulina e também ser causador do mofo azul, doença responsável por significativas perdas devido à podridão de frutos. o método descrito aqui possui vantagens se comparado aos métodos descritos anteriormente. dentre estas vantagens, destacam-se: o aumento do controle da qualidade dos produtos alimentícios originados de frutas que podem ser contaminadas pelo peniciltium expansum; o monitoramento pelo próprio técnico da empresa sem requerer elevado nível de qualificação da sua parte, bem como investimentos adicionais, quando comparado a técnicas já existentes; um menor intervalo de tempo para a detecção do patógeno, uma vez que as amostras não necessitam mais serem enviadas aos laboratórios de análises microbiológicas; dentre outras.
Patent EA-000874-B1 (EA)
Title: Pourable organic acid-based granulates
Inventor: BROCKEL ULRICH
IPC: A23K40/30
Filed: 1996-08-26
Abstract: 1. A pourable granulate comprising an organic acid applied on a porous carrier, characterized in that said granulates are coated with a casing, said casing comprises a covering agent which is water-soluble at 20 degree C or can swell in water. 2. A pourable granulate according to claim 1, characterized in that the casing further comprising a powdering means on its serface. 3. A pourable granulate according to claim 1, characterized in that the core comprises 30-90 wt. % of an organic acid. 4. A pourable granulate according to claim 1, characterized in that the organic acid is mono- or dicarbonic having 1 to 6 carbon atoms or a mixture of such carbonic acids. 5. A pourable granulate according to claim 1, characterized in that porous organic or inorganic materials are used as a carrier the particle size of which is 1-1000 mμm, preferably 5-100 mμm. 6. A pourable granulate according to claim 1, characterized in that water-soluble polymers, organic acids, salts thereof or low-melting inorganic salts are used as a casing material. 7. A pourable granulate according to claim 5, characterized in that grain siftings silicates, perlite or silicic acids amounting from 10 wt. % to 70 wt. %, preferably from 20 wt. % to 40 wt.% are used as a carrier. 8. A pourable granulate according to claim 6, characterized in that polyethylenglykole, polyvinylpyrrolidone, or organic acids, containing from 3 to 14 carbon atoms, preferably from 3 to 6 carbon atoms, particularly citric, fumaric, succinic, adipic, benzoic, sorbic acids and salts threof, or amonoacids and salts thereof.
Patent EA-004231-B1 (EA)
Title: Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
Inventor: SIKORSKI JAMES A
IPC: A61K31/235
Filed: 1999-12-17
Abstract: 1. A therapeutic combination comprising a first amount of a fibric acid derivative compound and a second amount of a cholesteryl ester transfer protein inhibiting compound wherein the first amount and the second amount together comprise an anti hyperlipidemic condition effective amount, an anti atherosclerotic condition effective amount, or an anti-hypercholesterolemic condition effective amount of the compounds. 2. The therapeutic combination of claim 1 wherein the fibric acid derivative compound comprises clofibrate. 3. The therapeutic combination of claim 1 wherein the fibric acid derivative compound comprises fenofibrate. 4. The therapeutic combination of claim 1 wherein the fibric acid derivative compound comprises ciprofibrate. 5. The therapeutic combination of claim 1 wherein the fibric acid derivative compound comprises bezafibrate. 6. The therapeutic combination of claim 1 wherein the fibric acid derivative compound comprises gemfibrozil. 7. The therapeutic combination of claim 1 wherein the fibric acid derivative compound comprises clinofibrate. 8. The therapeutic combination of claim 1 wherein the fibric acid derivative compound comprises binifibrate. 9. The therapeutic combination of claim 1 wherein the combination comprises a composition comprising the fibric acid derivative compound and the cholesteryl ester transfer protein inhibiting compound.
Patent EA-004076-B1 (EA)
Title: Multiphase venturi flow metering method
Inventor: KUSTERS ROEL MARIE
IPC: G01F1/36
Filed: 2000-06-29
Abstract: 1. A method for measuring fluid flow characteristics in a multiphase fluid stream which passes through a gradiometer-venturi flow meter, the method comprising: - measuring liquid holdup alpha1,I on the basis of n measurements of pressure drop along the gradiometer at or near the inlet of the venturi; - determining a slipfactor (S) which expresses the difference between the gas and liquid velocity at a selected location in the venturi, which slip factor is based on the measured level of liquid holdup; and - calculating the fluid flow characteristics on the basis of an algorithm which takes into account the measured liquid holdup and slip factor (S), characterized in that said algorithm takes into account the measured liquid holdup alpha1,I at the inlet of the venturi and different slip factors at the inlet (Si) and in the throat of the venturi (St). 2. The method of claim 1, wherein if the liquid holdup at the inlet of the venturi alpha1,I exceeds a pre-determined value slipfactors at the inlet of the venturi (Si) and in the throat of the venturi (St) are determined from empirical correlations, which slipfactors are used as input in a first algorithm, together with the pressure drop between the inlet and throat of the venturi, to calculate the superficial liquid velocity, whereas if the liquid holdup at the inlet of the venturi remains below the predetermined value then the slip factors (Si) and (St) are determined using empirical correlations given in a second algorithm. 3. The method of claim 2, wherein if the liquid holdup at the inlet of the venturi alpha1,I exceeds a predetermined value, it is assumed that bubble flow (BF) occurs and slipfactors at the inlet of the venturi (Si) and at the throat of the venturi (St) are determined from the empirical correlations and used as input in algorithm where together with the pressure drop between the inlet and the throat of the venturi, to calculate the superficial liquid velocity Vsl, whereas if the liquid holdup at the venturi remains below the predetermined value it is assumed that slug flow (SF) occurs and the slipfactors Si and St are determined from the empirical correlations where beta is diameters ratio at the inlet and in the throat of the venturi, g is constant gravitational acceleration, sigma is surface tension, rho is liquid density (rhol) and gas density (rho2) accordingly, Deltarhov is pressure drop by flow meter, Deltarhogradio is pressure drop along gradiometer, alpha is inclination angle, Lv is the length from the inlet to the throat of the venturi, Lgradio is the length of gradiometer, D is pipe diameter, A is cross section area at the inlet (Ai) and in the throat (At) of the venturi, ftp is two-phase constant of friction, Vm is mixture velocity, Vsl,i is superficial fluid velocity at the inlet, Meff is effective Mach number, alphag,l is liquid holdup at the inlet.
Patent EA-005365-B1 (EA)
Title: Method for treating arterial hypertension
Inventor: SOLOMATOV VIKTOR GENNADIEVICH
IPC: A61H39/00
Filed: 2002-03-20
Abstract: The method relates to medicine, namely to energoreflexotherapy and can be used for treating diseases associated with arterial hypertension an/or hypertension disease. The method comprises effecting upon biologically active points and/or energoreflexotherapy zones associated with medulla and cervical vegetative nodes activities, and/or reproductive organs activities, and/or elements of gastrointestinal tract, for example, hepatobiliary system, and/or musculoskeletal system. In the Inh-energotype the action is effected mainly upon biologically active points and/or energoreflexotherapy zones associated with the Yan organs, while In the Yan-energotype the action is effected mainly upon biologically active points and/or energoreflexotherapy zones associated with the Inh organs.
Patent EA-006504-B1 (EA)
Title: Process for recovering and purifying caprolactam from an organic solvent
Inventor: DSINTER-DE HONDT MARIA LOUISA
IPC: C07D201/16
Filed: 2002-02-27
Abstract: Process for recovering caprolactam from a solution comprising caprolactam dissolved in an organic solvent, said process comprising: a) washing the solution with water or an aqueous alkaline solution, resulting in a washed solution comprising caprolactam and organic solvent and in a washing residue, b) evaporating organic solvent from the washed solution, resulting in caprolactam product, c) optionally, hydrogenating the caprolactam product, d) optionally, evaporating water from the caprolactam product, e) distilling the caprolactam product to recover caprolactam and a distillation residue, f) extracting the distillation residue with an organic solvent in the presence of water to obtain (I) an extract comprising caprolactam dissolved in organic solvent and (ii) an aqueous effluent, and g) recycling the extract to step a) or b).
Patent EA-012260-B1 (EA)
Title: Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
Inventor: SWINNEN DOMINIQUE
IPC: A61P/
Filed: 2003-01-27
Abstract: The present invention is related to substituted methylene amide derivatives of formula (I)and also its geometrical isomers, its optically active forms as enantiomers, diastereomers and its racemate forms, as well as pharmaceutically acceptable salts and pharmaceutically active derivatives thereof, wherein Ris selected from the group consisting of (C-C) alkyl, CHA or CHCHA moieties (where A is optionally substituted (C-C)aryl or optionally substituted (C-C)heteroaryl), optionally substituted C-Caryl, (3-8-membered)cycloalkyl, (C-C)alkylaryl, mono, bi- or tricyclic heteroaryl with condensed rings, or 3-8-membered) heterocycloalkyl or (C-C)alkylheterocyclyl and which comprise 1-3 heteroatoms selected from oxygen, nitrogen or sulphur; Rand Rare each independently from each other selected from the group comprising or consisting of H or (C-C)alkyl; Cy is optionally substituted (C-C)alkyl, 5-6 membered heteroaryl group with one or several heteroatoms selected from N, O or S; thienyl or phenyl substituted optionally substituted by (C-C)aryl group or optionally substituted by 5-6 membered heteroaryl group with one or several heteroatoms selected from N, O or S; wherein that substituents may be selected from halo, C-Calkoxy, C-Caryloxy, ciano, nitro, C-Calkyl, haloalkyl, hydroxy, C-Calkenyl, C-Calkynyl, B-R, where B is ethynyl group, and Ris (C-C)alkylphenyl; -COR, -COOR, -CO-NRR, -NHCOR, where Ris (C-C)alkyl or (C-C)alkenyl, -SOR, -SOR, -SONRR, wherein R,Rare each independently from each other selected from the group comprising H, linear or branched (C-C)alkyl, (C-C)alkenyl, (C-C)alkynyl, (C-C)aryl, 5-6 membered heteroaryl group with one or several heteroatoms selected from N, O or S, (3-8-membered)cycloalkyl or heterocycloalkyl, (C-C)alkyl-aryl or heteroaryl. With the proviso that the following compounds are excluded:and use thereof for the treatment and/or prevention of metabolic disorders mediated by insulin resistance or pyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, obesity, polycystic ovary syndrome (PCOS). In particular, the present invention is related to the use of substituted methylene amide derivatives of formula (I) to modulate, notably to inhibit the activity of PTPs. Also the present invention relates to a method of treating diabetes type II, obesity and to regulate the appetite of mammals. The present invention is furthermore related to novel substituted methylene amide derivatives and method of preparation thereof.
Patent EA-009289-B1 (EA)
Title: THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-β
Inventor: SANDROCK ALFRED
IPC: A61K47/42
Filed: 2003-09-26
Abstract: The present invention provides methods for the treatment, and pharmaceuticals for the use in the treatment, of mammalian subjects having, or at risk of developing, chronic demyelinating neuropathies, e.g., CIDP. The methods involve the administration of IFN-beta therapeutics.
Patent EA-013400-B1 (EA)
Title: Method for treating tumor diseases
Inventor: KHOPERSKAJA OLGA ANATOLIEVNA
IPC: A61K36/714
Filed: 2006-01-23
Abstract: The invention relates to medicine and can be used for treating malignant and benign tumors. A method for treating tumor diseases involves administering Jungar monkshood based preparation into patient organism during the whole course of treatment divided to three steps, duration of which is 20 days, at the first step the Jungar monkshood based preparation is administered in daily increasing doses from 20 ng to 400 ng, at the second step administration is continued with 400 ng doses and additionally administer into patient organism a highly molecular regulatory protein of transforming growth factor family (TGF- β), at the third step the Jungar monkshood based preparation is further administered gradually reducing the dose from 400 ng to 20 ng. During the first step and at the end of the third step an immunomodulator is administered activating antitumor and antiviral activity of the immune system, wherein during the course of treatment phyto preparations are additionally administered including diuretic and cholagogic collections, antidepressants, antiparasitic collections of medicinal plants and/or preparations.
Patent EA-013328-B1 (EA)
Title: Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
Inventor: KOMPELLA AMALA KISHAN
IPC: A61P35/02
Filed: 2005-07-19
Abstract: The present invention relates to novel intermediates useful for the preparation of novel phenylaminopyrimidine derivatives, novel phenylaminopyrimidine derivatives, pharmaceutical composition containing the novel phenylaminopyrimidine derivatives and processes for their preparation. The invention particularly relates to novel phenylpyrimidine amine derivatives of the general formula (I)The novel compounds can be used in the therapy of Chronic Myeloid Leukemia (CML).
Patent EA-012246-B1 (EA)
Title: Method of treating or preventing bone deterioration of osteoporosis
Inventor: DUDLEY ROBERT E
IPC: A61K31/56
Filed: 2006-04-11
Abstract: The present invention relates to a transdermal hydroalcoholic testosterone gel formulation and a method for treating, preventing, or reducing the risk of developing deterioration of bone. The present invention also relates to a method for treating, preventing, or reducing the risk of developing osteoporosis.
Patent EA-013576-B1 (EA)
Title: Y-type fluid end with replaceable suction module
Inventor: JENSEN ERNEST JEROME
IPC: F04B53/10
Filed: 2007-12-10
Abstract: A fluid end assembly for a high pressure pump receives a fluid from a fluid supply manifold and supplies the fluid to an outlet manifold. The assembly includes a housing with a removable suction module. The housing has a plunger bore to receive a reciprocating plunger, a suction passage intersects said plunger bore, and a discharge passage intersects both said plunger bore and said suction passage.
Patent EA-014714-B1 (EA)
Title: Arylvinylazacycloalkane compounds, pharmaceutical composition based threon and methods for use thereof
Inventor: SCHMITT JEFFREY DANIEL
IPC: C07D405/14
Filed: 2004-03-04
Abstract: Novel vinylazacycloalkane compound of Formula (I) is disclosed. The compounds are ligands of various nAChRs. The compounds and their pharmaceutically acceptable salts can be used to prepare pharmaceutical compositions and/or medicaments intended to prevent or treat disorders associated with dysfunction on nAChRs, especially within the central nervous system or the gastrointestinal system. Examples of types of disorders that can be treated include neurodegenerative disorders, including central nervous system disorders such as Alzheimer's disease, cognitive disorders, motor disorders such as Parkinson's disease, drug addiction, behavioral disorders and inflammatory disorders within the gastrointestinal system. The compounds can also serve as analgesics in the treatment of acute, chronic or recurrent pain.
Patent EA-015051-B1 (EA)
Title: Method and device for desorption ionization by liquid jet
Inventor: TAKATS ZOLTAN
IPC: H01J27/00
Filed: 2007-05-31
Abstract: The invention relates to method and apparatus for production of gaseous ions from components of a condensed phase sample and analysis thereof, wherein one ore more liquid jet(s) is/are directed to the surface of the sample to be investigated, where the impact of the liquid jet on the sample surface produces droplets carrying sample particles which are turned into gaseous ions via the evaporation of liquid or, if desired, by a subsequent ionization after the evaporation and the obtained sample particles are analyzed by a known method.